Tech Company Financing Transactions
Alloy Therapeutics Funding Round
8VC, Alexandria Venture Investments and Echo participated in a $40 million Series E funding round for Alloy Therapeutics. This venture round was recorded on 4/16/2026.
Transaction Overview
Company Name
Announced On
4/16/2026
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series E
Investors
Proceeds Purpose
The company intends to use the funds to accelerate growth across three priorities: deepen its core discovery service in antibodies, genetic medicines, and cell therapies; expand its downstream preclinical and clinical development services; and accelerate its AI/ML and data layer.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
44 Hartwell Ave.
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Undisclosed
Website
Email Address
Overview
Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners, Alloy democratizes access to tools, technologies, services, and company creation capabilities that are foundational for discovering and developing therapeutic biologics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Errik Anderson
Chief Operating Officer
Jay Rosanelli
Chief Scientific Officer
Piotr Bobrowicz
VP - Bus. Development
Heather Schwoebel
VP - General Counsel
Patrick Bradley
VP - General Counsel
Logan Snyder
Browse more venture capital transactions:
Prev: 4/16/2026: Worki venture capital transaction
Next: 4/16/2026: Nula Therapeutics venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs